Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   HTML views PDF downloads Totals
13,755 Dovepress* 12,971+ 1,419 14,390
PubMed Central* 784 249 1,033
Totals 13,755 1,668 15,423
*Since 24 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed and Google Scholar